At a glance
- Originator Mitsubishi Chemical
- Developer Mitsubishi Chemical; Nonindustrial source
- Class Antivirals; Small molecules
- Mechanism of Action Tumour necrosis factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer; HIV infections
Most Recent Events
- 07 Jun 2001 No-Development-Reported for Cancer (Prevention)/Chemoprevention in Japan (Unknown route)
- 07 Jun 2001 No-Development-Reported for Cancer in Japan (Unknown route)
- 07 Jun 2001 No-Development-Reported for Cancer in USA (Unknown route)